Knobbe/Martens: Intellectual Property Law

Medical Blog

Medical Blog
Partner Bridget Smith was quoted in "Why PTAB filings are dropping and how they may affect medical device firms," an article published by Medical Plastics News/Med-Tech Innovation News. Published
Monday, August 12, 2019
in

Partner Bridget Smith was quoted in "Why PTAB filings are dropping and how they may affect medical device firms," an article published by Medical Plastics News/Med-Tech Innovation News.

Medical Blog
PTAB Institutes Inter Partes Review of Medtronic “Jervis” Patent Published
Thursday, June 27, 2019
in

On June 11, 2019, the U.S. Patent and Trademark Office Patent Trial and Appeal Board (PTAB) instituted inter partes review (IPR) of U.S. Patent No. 6,306,141, assigned to Medtronic Vascular, Inc.  The Decision instituted the IPR based on two obviousness grounds, including that “Petitioner has made an adequate showing at this stage that at least claim 1 would have been obvious over CraggPops, and Tanaka.”

Medical Blog
New Motion Sickness Glasses Launched Published
Thursday, June 27, 2019
in

In July 2018Citroënthe French car manufacturer, unveiled glasses that aid in alleviating motion sickness.  The “Seetoën” glasses, developed by Boarding Ring, purports to eliminate motion sickness symptoms within about 10 minutes of putting them on.  According to Boarding Ring, the Boarding Ring technology includes four rings filled with blue liquid.

Medical Blog
Boston Scientific Exercises Option to Acquire Transcatheter Annuloplasty Ring Developer Millipede Inc. Published
Tuesday, January 22, 2019
in

Global medical device company Boston Scientific has announced on December 27, 2018, that it exercised its option to acquire remaining shares of privately-held medical device company Millipede, Inc. upon its recent successful completion of a first-in-human clinical study.  Boston Scientific previously announced on January 24, 2018, an agreement to make a $90 million investment in Millipede.  The current press release states the prior agreement included an option for Boston Scientific to “acquire [Millipede’s] remaining shares for $325M at closing, with a $125M payment becoming available upon achievement of a commercial milestone.”

Medical Blog
A New Weapon against Obesity Published
Tuesday, January 22, 2019
in

A new study based on a novel implantable weight loss device that was published in Nature, has shown that it was able to help rats shed almost 40 percent of their body weight.  This implant device developed by engineers at the University of Wisconsin–Madison could offer a promising new weapon for the battle against obesity.  More than 700 million adults and children worldwide are obese, according to a 2017 study that called the growing number and weight-related health problems a “rising pandemic.”

Medical Blog
Medical Research Organization NAMSA Announces Acquisition of Reimbursement Strategies Consultancy Published
Tuesday, January 22, 2019
in

NAMSA, which describes itself as “the world’s only Medical Research Organization (MRO) that accelerates medical device development through integrated laboratory testing, clinical research and regulatory consulting services,” has announced the acquisition of Reimbursement Strategies, LLC.

Medical Blog
Garmin and ActiGraph Collaborate to Explore Health and Activity Monitoring Solutions on Wearable Devices Published
Tuesday, January 22, 2019
in

Garmin International, Inc. recently announced a collaboration with ActiGraph to create health and activity monitoring solutions for academic research, clinical trials, and remote patient monitoring.  The collaboration will combine Garmin wearables with ActiGraph‘s CentrePoint data analytics platform to achieve these goals

Medical Blog
Cook Medical Petitions for Inter Partes Review (IPR) of Medtronic “Jervis” Patent Published
Thursday, December 20, 2018
in

On November 9, 2018, Cook Medical LLC filed a petition with the Patent Trial and Appeal Board requesting inter partes review (IPR) of U.S. Patent No. 6,306,141, assigned to Medtronic Vascular, Inc.  The ‘141 Patent is entitled “Medical Devices Incorporating SIM Alloy Elements.”  The ‘141 Patent states that it relates to “a medical device containing a shape memory alloy element.”

Medical Blog
Cryoablation Competition Heats Up Published
Tuesday, December 11, 2018
in

Atrial fibrillation (AF), a common heart rhythm disorder, is often treated with cardiac ablation. Cardiac ablation uses RF (heating) or cryothermal (cooling) energy to scar the areas of the heart muscle that are responsible for the abnormal heart rhythm. Abbott Laboratories, Boston Scientific, and Biosense Webster (a subsidiary of Johnson & Johnson), each offer RF ablation catheters. According to one analyst, however, Medtronic is the first company to launch a cryoablation device and currently has reign over the cryoablation market. Recent developments suggest competition in cryoablation is now ramping up.

Medical Blog
Abbott Obtains FDA Approval for HeartMate 3 Device Published
Thursday, December 6, 2018
in

Abbott announced on October 19, 2018 that its HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S. Food and Drug Administration (FDA) approval as a destination therapy for people living with advanced heart failure. Physicians now can offer the HeartMate 3 system to patients not eligible for a transplant. The HeartMate 3 LVAD can serve as a permanent implant, allowing patients to live with the device for the rest of their lives.

Pages

Attorney Finder